Literature DB >> 25914517

Synthesis and anti-cancer activities of a water soluble gold(III) porphyrin.

Aaron D Lammer1, Melissa E Cook1, Jonathan L Sessler1.   

Abstract

Gold(III) compounds continue to be explored for their potential utility as anticancer agents. A recognized limitation is the reactivity of gold(III), which is typically reduced to the more labile gold(I) state under physiological conditions. The use of porphyrins can overcome this problem. However, to date the stabilization provided by the use a strongly chelating porphyrin is offset by the poor solubility of the resulting complex in aqueous media. In this work, we describe the synthesis and in vitro anti-cancer activity of a gold(III)porphyrin complex with relatively good aqueous solubility. As judged from standard antiproliferation assays, this complex displays an IC50 of 9 μM for the A2780 human ovarian cancer cell line. This is a higher level of potency than displayed by two related control systems.

Entities:  

Keywords:  anti-cancer; gold; porphyrin; solubility

Year:  2015        PMID: 25914517      PMCID: PMC4407279          DOI: 10.1142/S1088424615500236

Source DB:  PubMed          Journal:  J Porphyr Phthalocyanines        ISSN: 1088-4246            Impact factor:   1.811


  45 in total

1.  Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway.

Authors:  Daniela Saggioro; Maria Pia Rigobello; Lucia Paloschi; Alessandra Folda; Stephen A Moggach; Simon Parsons; Luca Ronconi; Dolores Fregona; Alberto Bindoli
Journal:  Chem Biol       Date:  2007-10

Review 2.  Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment.

Authors:  Chi-Ming Che; Raymond Wai-Yin Sun
Journal:  Chem Commun (Camb)       Date:  2011-06-14       Impact factor: 6.222

3.  A gold(III) porphyrin complex with antitumor properties targets the Wnt/beta-catenin pathway.

Authors:  Kim Hei-Man Chow; Raymond Wai-Yin Sun; Janice B B Lam; Carrie Ka-Lei Li; Aimin Xu; Dik-Lung Ma; Ruben Abagyan; Yu Wang; Chi-Ming Che
Journal:  Cancer Res       Date:  2009-12-08       Impact factor: 12.701

4.  Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.

Authors:  Luca Ronconi; Lorena Giovagnini; Christine Marzano; Frazia Bettìo; Rodolfo Graziani; Giuseppe Pilloni; Dolores Fregona
Journal:  Inorg Chem       Date:  2005-03-21       Impact factor: 5.165

Review 5.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

6.  Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia.

Authors:  Chalet Tan; Thomas A Waldmann
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

Review 7.  Interleukin 6 and its receptor: ten years later.

Authors:  T Hirano
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

8.  Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.

Authors:  Giordana Marcon; Stefania Carotti; Marcella Coronnello; Luigi Messori; Enrico Mini; Pierluigi Orioli; Teresita Mazzei; Maria Agostina Cinellu; Giovanni Minghetti
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

Review 9.  Potential for proteasome inhibition in the treatment of cancer.

Authors:  Julian Adams
Journal:  Drug Discov Today       Date:  2003-04-01       Impact factor: 7.851

10.  Gold(III) compounds as new family of anticancer drugs.

Authors:  Luigi Messori; Giordana Marcon; Pierluigi Orioli
Journal:  Bioinorg Chem Appl       Date:  2003       Impact factor: 7.778

View more
  5 in total

1.  Porphyrins and Metalloporphyrins Combined with N-Heterocyclic Carbene (NHC) Gold(I) Complexes for Photodynamic Therapy Application: What Is the Weight of the Heavy Atom Effect?

Authors:  Stefano Scoditti; Francesco Chiodo; Gloria Mazzone; Sébastien Richeter; Emilia Sicilia
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

Review 2.  Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.

Authors:  Inés Mármol; Cristina Sánchez-de-Diego; Alberto Pradilla Dieste; Elena Cerrada; María Jesús Rodriguez Yoldi
Journal:  Int J Mol Sci       Date:  2017-01-19       Impact factor: 5.923

3.  Plasmonic enhancement of the antibacterial photodynamic efficiency of a zinc tetraphenylporphyrin photosensitizer/dextran graft polyacrylamide anionic copolymer/Au nanoparticles hybrid nanosystem.

Authors:  Oleg A Yeshchenko; Nataliya V Kutsevol; Anastasiya V Tomchuk; Pavlo S Khort; Pavlo A Virych; Vasyl A Chumachenko; Yulia I Kuziv; Antonina P Naumenko; Andrey I Marinin
Journal:  RSC Adv       Date:  2021-12-20       Impact factor: 3.361

4.  Thermoresponsive Zinc TetraPhenylPorphyrin Photosensitizer/Dextran Graft Poly(N-IsoPropylAcrylAmide) Copolymer/Au Nanoparticles Hybrid Nanosystem: Potential for Photodynamic Therapy Applications.

Authors:  Oleg A Yeshchenko; Nataliya V Kutsevol; Anastasiya V Tomchuk; Pavlo S Khort; Pavlo A Virych; Vasyl A Chumachenko; Yulia I Kuziv; Andrey I Marinin; Lili Cheng; Guochao Nie
Journal:  Nanomaterials (Basel)       Date:  2022-08-02       Impact factor: 5.719

5.  Anticancer gold(iii)-bisphosphine complex alters the mitochondrial electron transport chain to induce in vivo tumor inhibition.

Authors:  Jong Hyun Kim; Samuel Ofori; Sean Parkin; Hemendra Vekaria; Patrick G Sullivan; Samuel G Awuah
Journal:  Chem Sci       Date:  2021-04-29       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.